CEO traces path from undergrad cancer biology interest to oncology biotech leadership | Filippo Petti, CEO, Celyad Oncology SA. 00:10:00

Share On Facebook Share On Twitter

The CEO shares a journey from undergraduate studies in cancer biology to leading an oncology biotech company, driven by personal experiences and professional insights, emphasizing the importance of science, business, and patient impact.

Recent Videos